Effects of therapy with dialyzable leukocyte extracts containing transfer factor activity on antibody-dependent cytotoxic activity in humans.
D000920:Antibody-Dependent Cell Cytotoxicity; D002179:Candidiasis, Cutaneous / Q000276:immunology; D003424:Crohn Disease / Q000276:immunology; D006566:Herpesviridae Infections / Q000276:immunology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007962:Leukocytes; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008545:Melanoma / Q000276:immunology; D011961:Receptors, Fc / Q000032:analysis; D012751:Sezary Syndrome / Q000276:immunology; D014165:Transfer Factor / Q000627:therapeutic use*; D014923:Wiskott-Aldrich Syndrome / Q000276:immunology
D011961:Receptors, Fc; D014165:Transfer Factor